Board member Sibyl Nichole Swift receives 1,572 cbdMD (YCBD) restricted stock units
Rhea-AI Filing Summary
Swift Sibyl Nichole reported acquisition or exercise transactions in this Form 4 filing.
cbdMD, Inc. director Sibyl Nichole Swift received a grant of 1,572 shares of Common Stock on April 14, 2026 as an equity award, bringing her direct holdings to 4,145 shares. The award is in the form of restricted stock units, each representing a right to one share of common stock.
The restricted stock units were granted as compensation for her service on the Board of Directors under the company’s 2021 or 2025 Equity Compensation Plan. They vest in four quarterly installments on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, and were approved in advance by the Compensation, Corporate Governance and Nominating Committee.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,572 shares
Net Buy
1 txn
Insider
Swift Sibyl Nichole
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,572 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 4,145 shares (Direct)
Footnotes (1)
- F1. Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.
Key Figures
RSUs granted: 1,572 shares
Grant price: $0.00 per share
Shares held after grant: 4,145 shares
+1 more
4 metrics
RSUs granted
1,572 shares
Restricted stock unit award on April 14, 2026
Grant price
$0.00 per share
Equity compensation grant, not open-market purchase
Shares held after grant
4,145 shares
Total direct holdings following the April 14, 2026 award
Vesting dates
June 30, 2026 to March 31, 2027
Four quarterly vesting dates for the RSU award
Key Terms
restricted stock units, Section 16(b), Rule 16b-3, Equity Compensation Plan
4 terms
restricted stock units financial
"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Section 16(b) regulatory
"The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-3 regulatory
"by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Equity Compensation Plan financial
"issued under the 2021 or 2025 Equity Compensation Plan as compensation"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did cbdMD (YCBD) disclose for Sibyl Nichole Swift?
cbdMD disclosed that director Sibyl Nichole Swift received 1,572 restricted stock units of Common Stock as an equity award. This grant increased her direct holdings to 4,145 shares, reflecting routine board compensation rather than an open-market purchase or sale.
What are the vesting dates for Sibyl Nichole Swift’s cbdMD (YCBD) restricted stock units?
The 1,572 restricted stock units vest in four quarterly installments. Vesting occurs on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, aligning the equity compensation schedule with her ongoing service on cbdMD’s Board of Directors.
Was Sibyl Nichole Swift’s cbdMD (YCBD) equity grant an open-market purchase?
No. The 1,572-share award was a grant of restricted stock units at a price of $0.00 per share, issued as compensation under cbdMD’s 2021 or 2025 Equity Compensation Plan, and approved by the Compensation, Corporate Governance and Nominating Committee.
Under which plan was the cbdMD (YCBD) restricted stock unit grant to Sibyl Nichole Swift issued?
The restricted stock units were issued under cbdMD’s 2021 or 2025 Equity Compensation Plan. They were granted as compensation for Swift’s services on the Board of Directors and approved by the Compensation, Corporate Governance and Nominating Committee composed of three non-employee directors.
How is Sibyl Nichole Swift’s cbdMD (YCBD) equity grant treated under Section 16(b)?
The grant was exempt from Section 16(b) short-swing profit rules under the Securities Exchange Act of 1934. It qualified for exemption through Rule 16b-3 because it was approved in advance by cbdMD’s Compensation, Corporate Governance and Nominating Committee of three non-employee directors.